首页 工具
登录
购物车
Sofosbuvir

Sofosbuvir

产品编号 T6676   CAS 1190307-88-0
别名: 索非布韦, GS 7977, PSI-7977

Sofosbuvir (GS 7977) 是一种丙型肝炎病毒聚合酶 NS5B 的尿苷单磷酸类似物抑制剂,用作治疗慢性丙型肝炎的抗病毒剂。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Sofosbuvir Chemical Structure
Sofosbuvir, CAS 1190307-88-0
规格 价格/CNY 货期 数量
5 mg ¥ 369 现货
10 mg ¥ 497 现货
50 mg ¥ 637 现货
100 mg ¥ 764 现货
500 mg ¥ 1,098 现货
1 g ¥ 1,297 现货
1 mL * 10 mM (in DMSO) ¥ 423 现货
其他形式的 Sofosbuvir:
产品目录号及名称: Sofosbuvir (T6676)
点击图片重新获取验证码
选择批次  
纯度: 99.93%
纯度: 99.82%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Sofosbuvir (GS 7977) is a uridine monophosphate analog inhibitor of hepatitis C virus (HCV) polymerase NS5B that is used as an antiviral agent in the treatment of chronic hepatitis C.
靶点活性 HCV RNA:92 nM(EC50)
体外活性 As HCV NS5B polymerase inhibitor, PSI-7977 displays more potent inhibitory activity against HCV RNA replication than PSI-7976 with EC50 of 92 nM versus 1.07 μM and EC90 of 0.29 μM versus 2.99 μM, consistent with that incubating clone A cells with PSI-7977 leads to a higher concentration of PSI-7409 than clone A cells incubated with PSI-7976. PSI-7977 is an effective substrate for CatA to form PSI-352707 with 18-30 fold more potency as compared with PSI-7976. Unlike GS-7976, however, the CES1-mediated hydrolysis of PSI-7977 does not progress in a time-dependent manner. [1] The S282T NS5B polymerase mutation but not S96T mutation confers resistance to PSI-7977 with EC90 increases from 0.42 μM to 7.8 μM. When assessed in an 8-day cytotoxicity assay, PSI-7977 displays no cytotoxicity against Huh7, HepG2, BxPC3, and CEM cells even at concentrations up to 100 μM. PSI-7977 treatment for 14 days shows a IC90 of 72.1 μM and 68.6 μM for the inhibition of mtDNA and rDNA, respectively, in HepG2 cells. [2] PSI-7977 exhibits potent activity against genotype (GT) 1a, 1b, and 2a (strain JFH-1) replicons and chimeric replicons containing GT 2a (strain J6), 2b, and 3a NS5B polymerase. Sequence analysis of the JFH-1 NS5B region indicates that additional amino acid changes including T179A, M289L, I293L, M434T, and H479P are selected both prior to and after the emergence of S282T, which are required to confer resistance to PSI-7977. [3]
激酶实验 PTEN Inhibition Assay: To determine the dose response of potential PTEN inhibitors, doses of test compounds ranging from 1 nM to 250 uM (final reaction mix concentrations) are evaluated in the general PTEN inhibition assay. To obtain performed IC50 data, two separate rounds of the dose response assay are performed. In the first round, PTEN activity is tested in the presence of inhibitor at 10 fold serial dilutions ranging from 1 nM to 250 uM. Once the concentration range is determined, at which PTEN activity changes dramatically, two additional concentration data points within this range are added and the PTEN inhibition assay is then rerun for the second round. The PTEN inhibition IC50 is presented as the inhibitor concentration at which 50% of the PTEN activity. When the assay was run on multiple occasions and gave slightly different IC50 then those are reported as a range of IC50 found.
细胞实验 Cells are exposed to various concentrations of PSI-7977 for 8 days. At the end of the growth period, MTS dye from the CellTiter 96 AQueous One Solution Cell Proliferation Assay kit is added to each well, and the plate is incubated for an additional 2 hours. The absorbance at 490 nm is read with a Victor3 plate reader using themedium only controlwells as blanks. The 50% inhibition value (IC50) is determined by comparing the absorbance in wells containing cells and PSI-7977 to untreated cell control wells.(Only for Reference)
别名 索非布韦, GS 7977, PSI-7977
分子量 529.45
分子式 C22H29FN3O9P
CAS No. 1190307-88-0

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

Ethanol: 93 mg/mL (175.7 mM)

DMSO: 93 mg/mL (175.7 mM)

H2O: 9 mg/mL (17 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
Ethanol / DMSO / H2O 1 mM 1.8888 mL 9.4438 mL 18.8875 mL 47.2188 mL
5 mM 0.3778 mL 1.8888 mL 3.7775 mL 9.4438 mL
10 mM 0.1889 mL 0.9444 mL 1.8888 mL 4.7219 mL
Ethanol / DMSO 20 mM 0.0944 mL 0.4722 mL 0.9444 mL 2.3609 mL
50 mM 0.0378 mL 0.1889 mL 0.3778 mL 0.9444 mL
100 mM 0.0189 mL 0.0944 mL 0.1889 mL 0.4722 mL

计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

参考文献

1. Murakami E, et al. J Biol Chem, 2010, 285(45), 34337-34347. 2. Sofia MJ, et al. J Med Chem, 2010, 53(19), 7202-7218. 3. Lam AM, et al. Antimicrob Agents Chemother, 2012, 56(6), 3359-3368.
Deapioplatycodin D 2'-MeCCPA Sofosbuvir impurity H VCH-916 free acid(1200133-34-1 free base) NS5A-IN-3 ABT530 GS-443902 Ribavirin

相关化合物库

该产品包含在如下化合物库中:
抗癌临床化合物库 抗癌上市药物库 抗癌药物库 抗衰老化合物库 抗肝癌化合物库 已知活性化合物库 共价抑制剂库 DNA 损伤和修复分子库 抗病毒库 抗COVID-19化合物库

剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Sofosbuvir 1190307-88-0 Microbiology/Virology Proteases/Proteasome HCV Protease 索非布韦 inhibit Inhibitor HCV GS7977 GS 7977 PSI7977 PSI-7977 Hepatitis C virus GS-7977 PSI 7977 inhibitor

 

陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼